Acknowledgments Under the direction of the authors, medical writing and editorial support, including the literature search, were provided by Graham Allcock of Axis, a division of Spirit Medical Communications Group Limited (funded by Novo Nordisk A/S)
However, the sample size in that study was small, as only 16 rats (eight per group) were used in their experiment, and the study duration was short (11 days), which may have affected the statistical significance and generalizability of the results
Learning Objectives Understand how incretin signaling (GLP-1 and GIP) integrates with insulin and glucagon across organs to regulate glucose homeostasis, appetite, and energy balance
Ideal als Abnehmpille
Trained immunity: a memory for innate host defense
What is known about effectiveness and safety At present, there is limited high-quality clinical evidence showing that commercially available GLP-1 patches lead to meaningful weight loss or blood sugar improvement